Osaic Holdings’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Osaic Holdings’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,908	Closed	-$741	–	7716
2023 Q1	$741	Buy	2,908 +1,750	+151%	+$1.58K	﹤0.01%	7047
2022 Q4	$1K	Buy	1,158 +244	+27%	+$513	﹤0.01%	7056
2022 Q3	$2K	Hold	914	–	–	﹤0.01%	6899
2022 Q2	$1K	Buy	+914	New	+$3.57K	﹤0.01%	7234
2022 Q1	–	Sell	-914	Closed	-$6K	–	7700
2021 Q4	$6K	Buy	+914	New	+$8.16K	﹤0.01%	6587

Osaic Holdings's PEAR Position: Q2 2023 in Review

Osaic Holdings sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 2,908 shares — an estimated $741 sold.

Osaic Holdings first reported a position in PEAR in Q4 2021 and held it in 5 quarters. The position peaked at $6K in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Osaic Holdings reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 2,908 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $741.
Osaic Holdings first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Osaic Holdings's Pear Therapeutics, Inc. Class A Common Stock position peaked at $6K in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.